FDA Issues Warning on Osteoporosis Medication

Mireya Hernandez
February 4, 2009
Mireya Hernandez

The Food and Drug Administration came out with some important news on bisphosphonates last month. Bisphosphonates are a common treatment and prevention medication for osteoporosis, and are marketed through brands like Boniva, Fosamax, Actonel and Reclast.

The report warns physicians of the possibility of bone, joint and/or muscle pain connected to the use of these drugs. It can take anywhere from days to years after starting the medication for the pain to start. And it can be very severe.

The FDA report says in nearly all cases, the pain stopped when the medication was cut off. More…

PainCareMD